Yoshihiro Nishida

41PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jun 12, 2026
Clinical Outcome in Elderly Patients (Aged ≥ 65 Years) Treated with Chemotherapy for Advanced Soft Tissue Sarcomas: A Tokai Musculoskeletal Oncology Consortium Study.

|Mar 18, 2026
Real-world outcomes for selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas in Japan: A 1-year interim analysis.

Yoshihiro Nishida, Akiyo Kitajima, Tomonori Ishii

|Mar 15, 2026
Analysis of the Relationship Between Survival and Postoperative Infection in Patients With Osteosarcoma.

Satoshi Kamio, Koichi Ogura, Kenji Sato

|Feb 07, 2026
Fatal Pericarditis and Cardiac Tamponade During Selumetinib Treatment for Pericardial Neurofibroma.

Sachina Sato, Hanako Koguchi-Yoshioka, Kazunori Yokoi

|Oct 21, 2025
Meflin is a druggable target using antibody-drug conjugates in progressive osteosarcoma.

Nobutoshi Esaki, Tomoka Sakoda, Ryota Ando

|May 12, 2025
Clinical factors associated with valgus knee deformities in patients with multiple osteochondromas.

Kan Ito, Yoshihiro Nishida, Kunihiro Ikuta

Pageof 7

Frequent Collaborators

5 joint publications

Hiroshi Urakawa

4 joint publications

Tomoki Nakamura

3 joint publications

Akira Kawai

3 joint publications

Makoto Endo